Rho GTPases as therapeutic targets in cancer and other human diseases

被引：0

作者：

Lorenzano Menna, Pablo ^{[1
]}

Cardama, Georgina A. ^{[1
]}

Comin, Maria J. ^{[2
]}

Alonso, Daniel F. ^{[1
]}

Gomez, Daniel E. ^{[1
]}

机构：

[1] Univ Nacl Quilmes, Oncol Mol Lab, Dept Ciencia & Tecnol, RA-1876 Buenos Aires, DF, Argentina

[2] INTI, Ctr Invest & Desarrollo Quim, Buenos Aires, DF, Argentina

来源：

MEDICINA-BUENOS AIRES | 2010年 / 70卷 / 06期

关键词：

cell signaling; cytoskeleton; cell migration; neurodegenerative diseases; cancer; PROTEIN-KINASE-C; MAMMARY-CARCINOMA CELLS; GDP EXCHANGE FACTOR; ANTIESTROGEN RESISTANCE; BREAST-CANCER; RAC3; GTPASES; ACTIVATION; RAS; TIAM1; INHIBITORS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Rho GTPases as therapeutic targets in cancer and other human diseases. Rho GTPases are a key protein family controlling the transduction of external signals to cytoplasmatic and nuclear effectors. In the last few years, the development of genetic and pharmacological tools has allowed a more precise definition of the specific roles of Rho GTPases. The aim of this review is to describe the cellular functions regulated by these proteins with focus on the molecular mechanism involved. We also address the role of Rho GTPases in the development of different human diseases such as cancer. Finally, we describe different experimental therapeutic strategies with Rho GTPases as molecular targets.

引用

页码：555 / 564

页数：10

共 50 条

[41] Open questions: what about the ‘other’ Rho GTPases?
Anne J. Ridley
BMC Biology, 14
[42] Rho GTPases: Anti- or pro-neoplastic targets?
I Zandvakili
Y Lin
J C Morris
Y Zheng
Oncogene, 2017, 36 : 3213 - 3222
[43] Rho GTPases: Anti- or pro-neoplastic targets?
Zandvakili, I.
Lin, Y.
Morris, J. C.
Zheng, Y.
ONCOGENE, 2017, 36 (23) : 3213 - 3222
[44] Rho GTPases: Promising cellular targets for novel anticancer drugs
Fritz, G
Kaina, B
CURRENT CANCER DRUG TARGETS, 2006, 6 (01) : 1 - 14
[45] Hypoxia signaling in human diseases and therapeutic targets
Lee, Jae W.
Ko, Junsuk
Ju, Cynthia
Eltzschig, Holger K.
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 51 (6): : 1 - 13
[46] Hypoxia signaling in human diseases and therapeutic targets
Jae W. Lee
Junsuk Ko
Cynthia Ju
Holger K. Eltzschig
Experimental & Molecular Medicine, 2019, 51 : 1 - 13
[47] Rho GTPases in human cancer:: an unresolved link to upstream and downstream transcriptional regulation
Benitah, SA
Valerón, PF
van Aelst, L
Marshall, CJ
Lacal, JC
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2004, 1705 (02): : 121 - 132
[48] Regulation of Rho GTPases by RhoGDIs in Human Cancers
Cho, Ee Jun
Kim, Jong-Tae
Baek, Kyoung Eun
Kim, Bo-Yeon
Lee, Hee Gu
CELLS, 2019, 8 (09)
[49] Role of Rho GTPases and their regulators in cancer progression
Rathinam, Rajamani
Berrier, Allison
Alahari, Suresh K.
FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 2561 - 2571
[50] Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Siebert, Stefan
Tsoukas, Alexander
Robertson, Jamie
McInnes, Iain
PHARMACOLOGICAL REVIEWS, 2015, 67 (02) : 280 - 309

← 1 2 3 4 5 →